Z-0772-2020 Class II Terminated

Recalled by Nucletron BV — Veenendaal, N/A

FDA device recall Z-0772-2020 was initiated by Nucletron BV on Nov 18, 2019 and is designated Class II. Reason for recall: A component failure may lead to treatment interruption or incorrect source positioning. The recall status is terminated (terminated Mar 28, 2023). Affected quantity: 383.

Recall details

Product Type
Devices
Report Date
Jan 8, 2020
Initiation Date
Nov 18, 2019
Termination Date
Mar 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
383

Product description

There is a complaint regarding internal check cable guide mechanism failure for the Nucletron Flexitron brachytherapy afterloader system. Due to an obstruction during the check cable out drive, the internal guiding tube became displaced and the check cable became damaged. This issue could cause treatment interruption or in a very unlikely scenario, incorrect source positioning and radiation treatment errors.

Reason for recall

A component failure may lead to treatment interruption or incorrect source positioning.

Distribution pattern

Distribution in United States and worldwide

Code information

REF 136149A02; UDI: (01)08717213051126 (11)171127 (21)FT00340 (240)136149

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0772-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Nucletron BV? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0772-2020. Report a data issue: hello@regdatalab.com.